Evolus, Inc. (EOLS) |
11.69 0.09 (0.78%)
|
07-02 20:32 |
Open: |
11.6 |
Pre. Close: |
11.6 |
High:
|
11.85 |
Low:
|
11.5 |
Volume:
|
227,900 |
Market Cap:
|
655(M) |
|
|
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California. |
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
11.86 - 11.91 |
11.91 - 11.96 |
Low:
|
11.38 - 11.43 |
11.43 - 11.48 |
Close:
|
11.6 - 11.68 |
11.68 - 11.77 |
|
Technical analysis |
as of: 2022-07-01 4:21:38 PM |
Overall:
|
|
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
Target: |
Six months: 14.92 One year: 16.7 |
Support: |
Support1: 10.31 Support2: 8.57 |
Resistance: |
Resistance1: 12.77 Resistance2: 14.3 |
Pivot: |
11.78  |
Moving Average: |
MA(5): 11.91 MA(20): 11.93 
MA(100): 11.18 MA(250): 9.3  |
MACD: |
MACD(12,26): -0.1 Signal(9): -0.1  |
Stochastic oscillator: |
%K(14,3): 45.3 %D(3): 51.4  |
RSI: |
RSI(14): 46.4  |
52-week: |
High: 14.34 Low: 5.06 |
Average Vol(K): |
3-Month: 522 (K) 10-Days: 461 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ EOLS ] has closed above bottom band by 44.3%. Bollinger Bands are 24.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Headline News |
Tue, 28 Jun 2022 Evolus, Inc. (NASDAQ:EOLS) Receives $15.33 Consensus Target Price from Brokerages - Defense World
Wed, 15 Jun 2022 County libraries offer summer opportunities - Sequoyah County Times
Tue, 14 Jun 2022 Shareholders in Evolus (NASDAQ:EOLS) have lost 19%, as stock drops 11% this past week - Simply Wall St
Sun, 12 Jun 2022 Our view: A first-class show in Union - La Grande Observer
Mon, 23 May 2022 Evolus Inc (EOLS) has fallen -15.38% in a Week, Should You Accumulate? - InvestorsObserver
Wed, 11 May 2022 Evolus stock rises as Q1 revenue soars 177% Y/Y - Seeking Alpha
|
Financial Analysis |
Price to Book Value: |
Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Underperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NASDAQ |
Sector: Healthcare |
Industry: Drug Manufacturers—Specialty & Generic |
Shares Out. |
56 (M) |
Shares Float |
37 (M) |
% Held by Insiders
|
33.4 (%) |
% Held by Institutions
|
46.3 (%) |
Shares Short
|
3,040 (K) |
Shares Short P.Month
|
2,280 (K) |
Stock Financials |
EPS
|
-1.3 |
EPS Est Next Qtl
|
0 |
EPS Est This Year
|
0 |
EPS Est Next Year
|
0 |
Book Value (p.s.)
|
1.2 |
Profit Margin (%)
|
-58.3 |
Operating Margin (%)
|
-50.8 |
Return on Assets (ttm)
|
-20.4 |
Return on Equity (ttm)
|
-156.3 |
Qtrly Rev. Growth
|
177 |
Gross Profit (p.s.)
|
1 |
Sales Per Share
|
2.16 |
EBITDA (p.s.)
|
-1.02 |
Qtrly Earnings Growth
|
0 |
Operating Cash Flow
|
-63 (M) |
Levered Free Cash Flow
|
-33 (M) |
Stock Valuations |
PE Ratio
|
-9 |
PEG Ratio
|
-0.8 |
Price to Book value
|
9.74 |
Price to Sales
|
5.39 |
Price to Cash Flow
|
-10.36 |
Stock Dividends |
Dividend
|
0 |
Forward Dividend
|
0 |
Dividend Yield
|
0% |
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
7 Binary Options
|
Your Ad Here
|
|